Cambrex Drug Product- Business Unit - Ownership and Business Overview

Healthcare ServicesCompany

Cambrex Drug Product- Business Unit Ownership

Who owns Cambrex Drug Product- Business Unit?

Cambrex Drug Product- Business Unit is owned by Noramco. It was acquired on November 2, 2023.

Was Cambrex Drug Product- Business Unit formerly PE-backed?

Yes. Cambrex Drug Product- Business Unit was formerly owned by 1 private investor.

Cambrex Drug Product- Business Unit Business Overview

Where is Cambrex Drug Product- Business Unit headquartered?

Cambrex Drug Product- Business Unit is headquartered in Whippany, New Jersey.

What sector is Cambrex Drug Product- Business Unit in?

Cambrex Drug Product- Business Unit is a healthcare services company.

When was Cambrex Drug Product- Business Unit founded?

Cambrex Drug Product- Business Unit was founded in 2006.

Healthcare Services M&A Summary in 2023

Out of 60 sectors in the Mergr database, healthcare services ranked 6 in number of deals in 2023. The largest healthcare services acquisition in 2023 was Amedisys - which was acquired by Optum for $3.3B.

Join Mergr to view all 277 acquisitions of healthcare services companies in 2023, including 42 acquisitions by private equity firms, and 235 by strategics.

Cambrex Drug Product- Business Unit

Cambrex Drug Product- Business Unit

30 North Jefferson Road,
Whippany, New Jersey 07981
United States,
(973) 428-4000

Cambrex Drug Product's Business Unit is a technology-focused contract manufacturing business with differentiated applications and capabilities in solid, semi-solid and liquid dosage forms, with a particular focus on controlled substances. Cambrex Drug Product's Business Unit was established in 2006 and is based in Whippany, New Jersey.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.